Balance Sheet
Cash Flow Statement
Capital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Vivos Therapeutics (VVOS) Other financing activities (2021 - 2024)

Vivos Therapeutics has reported Other financing activities over the past 3 years, most recently at $500000.0 for Q4 2024.

  • Quarterly Other financing activities rose 15.74% to $500000.0 in Q4 2024 from the year-ago period, while the trailing twelve-month figure was $1.0 million through Dec 2025, down 28.69% year-over-year, with the annual reading at $837000.0 for FY2025, 38.5% down from the prior year.
  • Other financing activities was $500000.0 for Q4 2024 at Vivos Therapeutics, down from $509000.0 in the prior quarter.
  • Over five years, Other financing activities peaked at $645000.0 in Q1 2023 and troughed at $4000.0 in Q3 2021.
  • The 3-year median for Other financing activities is $432000.0 (2023), against an average of $356571.4.
  • The largest YoY upside for Other financing activities was 15.74% in 2024 against a maximum downside of 52.56% in 2024.
  • A 3-year view of Other financing activities shows it stood at $4000.0 in 2021, then soared by 10700.0% to $432000.0 in 2023, then increased by 15.74% to $500000.0 in 2024.
  • Per Business Quant, the three most recent readings for VVOS's Other financing activities are $500000.0 (Q4 2024), $509000.0 (Q3 2024), and $100000.0 (Q2 2024).